Kentucky, Alaska and Alabama are the three states where weight loss ... approved for obesity in 2014—using the active ingredient liraglutide, under the brand name Saxenda—claims for the drugs rapidly ...
Recent health news covers Vertex Pharmaceuticals' revenue uptick due to cystic fibrosis treatments, Britain's detection of ...
She could go to a med-spa, but that would cost about $1,000 a month, still too much for the new therapist ... it became the ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Novo Nordisk A/S (NYSE:NVO) is advancing its research on a pioneering hybrid drug, CagriSema. This drug merges semaglutide ...
European Union antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings’ acquisition of contract drug ...
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...
“This is a priority for [the authority] — the development of new products that can be used to address these types of threats, ...
Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication ...
Eli Lilly ( LLY) is planning to advertise its blockbuster weight loss drug, Zepbound, for the first time next month. Despite ...
GoodRx has officially entered the weight loss drug market by offering an exclusive discount on the once-daily oral medication Qsymia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback